Related Articles
Concurrent TP53 mutations predict a poor prognosis of EGFR‑mutant NSCLCs treated with TKIs: An updated systematic review and meta‑analysis
Prognostic value of KRAS/TP53/PIK3CA in non‑small cell lung cancer
Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer
Influence of mutation type on prognostic and predictive values of TP53 status in primary breast cancer patients
Association between EGFR exon 19 or exon 21 mutations and survival rates after first‑line EGFR‑TKI treatment in patients with non‑small cell lung cancer